352 followers
RT @FrontOncology: New research: Toripalimab in combination with Anlotinib for unresectable hepatocellular carcinoma after SBRT: A prospect…
RT @FrontOncology: New research: Toripalimab in combination with Anlotinib for unresectable hepatocellular carcinoma after SBRT: A prospect…
New research: Toripalimab in combination with Anlotinib for unresectable hepatocellular carcinoma after SBRT: A prospective, single-arm, single-center clinical study: Objective Exposing tumor antigens to the immune system is the key to… https://t.co/Bk8d9